跳至主要内容
临床试验/NCT01570179
NCT01570179已完成3 期

Sugammadex in Patients Undergoing Bariatric Surgery: An Equivalence Trial Comparing Real and Ideal Body Weight-based Dosing

Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
100% TOF-recovery 3 min after sugammadex

研究概览

简要总结

Should the dose of sugammadex in morbid obese patients be calculated on the real body weight or the ideal body weight?

The main objective of the trial is to compare in patients undergoing bariatric surgery the efficacy of sugammadex to obtain a TOF-ratio of 100% within 3 min when dosing is based on real body weight (control intervention) with dosing based on ideal body weight (experimental intervention). The research hypothesis is that both dosing regimens are equivalent

The secondary objective of the trial is to compare the impact of the depth of neuromuscular blockade on the surgical conditions: deep block (TOF-count 1 - 3) will be compared with very deep block (TOF count = 0 and PTC < 5)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients undergoing bariatric surgery according to the respective criteria of the French Medical Authority (HAS) and having given their written informed consent after appropriate information

排除标准

  • not fulfilling the inclusion criteria, known or suspected allergy to any of the drugs used in that study, absence of written informed consent,doubt of pregnancy in women of childbearing age, pregnancy and breast feeding

研究组 & 干预措施

deep block ideal body weight

Experimental

干预措施: ideal body weight based sugammadex reversal of deep block (Drug)

deep block real body weight

Active Comparator

干预措施: real body weight based sugammadex reversal of deep block (Drug)

moderate block ideal body weight

Experimental

干预措施: ideal BW based sugammadex reversal of moderate block (Drug)

moderate block real body weight

Active Comparator

干预措施: real body weight based sugammadex reversal of moderate block (Drug)

结局指标

主要结局

100% TOF-recovery 3 min after sugammadex

时间窗: 3 min

次要结局

  • impact of depth of block on surgical conditions(every 15 min during surgery)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Sugammadex-dosing in Bariatric Patients | 临床试验